Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Multiple Dose Phase II Pharmacokinetic Study of KRP-AB1102 in COPD
jRCT2080221868Phase 2
- Sponsor
- Kyorin Pharmaceutical
- Start
- Jul 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of aclidinium in chronic obstructive pulmonary disease (COPD), sponsored by Kyorin Pharmaceutical. Primary endpoint: Primary pharmacokinetic endpoints.
02
Drugs
aclidinium
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on jRCT2080221868.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221868.